Simplex Trading
JSPR icon

Simplex Trading’s Jasper Therapeutics JSPR Stock Holding History

Simplex Trading’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$788 Sell
900
-300
-25% -$416 ﹤0.01% 8651
2025
Q4 		$2.2K Buy
+1,200
New +$2.41K ﹤0.01% 7804
2025
Q1 		– Sell
-100
Closed -$2K – 9064
2024
Q4 		$2K Sell
100
-900
-90% -$18.7K ﹤0.01% 8022
2024
Q3 		$18K Sell
1,000
-8,600
-90% -$171K ﹤0.01% 6746
2024
Q2 		$217K Buy
9,600
+2,600
+37% +$62.4K ﹤0.01% 4578
2024
Q1 		$205K Buy
+7,000
New +$124K ﹤0.01% 4823
2022
Q3 		– Sell
-80
Closed -$1K – 10395
2022
Q2 		$1K Buy
+80
New +$2.28K ﹤0.01% 9603

Other funds holding JSPR

VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

Simplex Trading's JSPR Position: Q1 2026 in Review

Simplex Trading opened a new position in Jasper Therapeutics (JSPR) in Q1 2026: 29,273 shares worth $25.6K. The stake represents ﹤0.01% of the portfolio and ranks #6549 among its holdings. This is a return to the name: Simplex Trading previously reported a position in JSPR as recently as Q2 2025.

Simplex Trading first reported a position in JSPR in Q4 2021 and has held it in 9 quarters since. The position peaked at $132K in Q2 2024. 58 funds tracked by Wall St. Rank hold JSPR as of Q1 2026.

  • Simplex Trading held 29,273 shares of Jasper Therapeutics worth $25.6K as of Q1 2026.
  • Jasper Therapeutics was a new Simplex Trading position in Q1 2026.
  • Jasper Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6549 holding.
  • Simplex Trading first reported a position in Jasper Therapeutics in Q4 2021 and has held it in 9 quarters since.
  • Simplex Trading's Jasper Therapeutics position peaked at $132K in Q2 2024.
  • 58 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.